Drugs / PEG 4000
PEG 4000
also known as
Polyethylene glycol 4000 · Macrogol 4000 · PEG · Forlax · Polyethylene Glycol · Polyethylene Glycol Electrolytes Powder
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT03106922 | Apr 2016 → Jul 2020 | — | Alfasigma S.p.A. | Unknown | No outcome recorded |
| Phase 3 | NCT00255372 | Apr 2005 → May 2008 | constipation disorder | Ipsen | Completed | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT05570669 | May → Dec 2021 | — | Italian Society of Digestive Endoscopy | Completed | No outcome recorded |
| Phase 4 | NCT01875744 | Jun → Nov 2013 | constipation disorder | Medical University of Warsaw | Completed | No outcome recorded |
| Phase 4 | NCT00603681 | Jan → Jul 2008 | constipation disorder | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
| Phase 4 | NCT01783782 | Nov 2005 → Aug 2013 | — | Azienda Policlinico Umberto I | Unknown | No outcome recorded |
| Phase 4 | NCT00276354 | Dec 1999 → Nov 2001 | constipation disorder | Ipsen | Completed | No outcome recorded |
| Phase not applicable4 trials | ||||||
| — | NCT06357897 | May 2024 → Dec 2026 expected | constipation disorder | Chulalongkorn University | Recruiting | No outcome recorded |
| — | NCT04605432 | Oct 2020 → Jun 2021 | — | Ningbo No. 1 Hospital | Completed | No outcome recorded |
| — | NCT04247386 | Dec 2019 → Aug 2020 | — | Ningbo No. 1 Hospital | Completed | No outcome recorded |
| — | NCT03146052 | Mar → May 2017 | polyp | ASST Rhodense | Completed | No outcome recorded |
Also used as a comparator or background therapy in 7 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 33 trials | ||||||
| Phase 3 | NCT03639142 Comparator | Sep 2018 → Sep 2020 | constipation disorder | Medical University of Warsaw | Unknown | No outcome recorded |
| Phase 3 | NCT02292459 Comparator | Dec 2015 | constipation disorder | Bayer | Withdrawn | No outcome recorded |
| Phase 3 | NCT01330381 Comparator | Apr 2011 → Mar 2013 | constipation disorder | Shire | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT03742232 Comparator | Oct 2018 → Mar 2020 | colon adenoma, polyp of colon | Istituto Clinico Humanitas | Completed | No outcome recorded |
| Phase 4 | NCT02751411 Comparator | Apr 2016 → Dec 2019 | constipation disorder | Aboca | Completed | No outcome recorded |
| Phase 4 | NCT02073552 Comparator | May 2014 → Dec 2015 | — | Fundación Canaria Rafael Clavijo para la Investigación Biomédica | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05648318 Comparator | Jan → Sep 2022 | colonic neoplasm | Zhang Xiaofeng,MD | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 18 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG 4000 | “patient in the PEG group were instructed to drink 2L of PEG (each liter containing 59g PEG 4000, 1.46g sodium chloride, 5.68g sodium sulfate, 0.74g potassium chloride, 1.68g...” NCT05648318 ↗8“Polyethylene Glycol 4000 Powder for Solution (PEG 4000)” NCT02292459 ↗ “60gPEG-4000 was mixed with 1L water” NCT04605432 ↗ “Polyethylene Glycol (PEG-4000)” NCT04247386 ↗ |
| Known as | Forlax | “PEG 4000 (Forlax ®)” NCT00276354 ↗1“PEG 4000 (Forlax®)” NCT00255372 ↗ |
| Known as | Macrogol 4000 | “Sachet A: macrogol 4000 52.500 g, anhydrous sodium sulphate 3.750 g, simeticone 0.080 g;” NCT03106922 ↗ |
| Known as | PEG | “Children with functional constipation according to the Rome IV criteria will be randomly assigned to receive prunes at dose 3.5 g/kg/d (prune group) or Polyethylene Glycol 4000...” NCT03639142 ↗2“Polyethylene glycol 4000: 16 envelopes (70 g of powder each). It includes electrolytes and sodium sulfate. These substances make PEG metabolically inert, achieving a suitable...” NCT02073552 ↗ |
| Known as | Polyethylene Glycol | “120g Polyethylene Glycol (PEG-4000)” NCT04247386 ↗1“polyethylene glycol (PEG)” NCT05648318 ↗ |
| Known as | Polyethylene glycol 4000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00603681 ↗ |
| Known as | Polyethylene Glycol Electrolytes Powder | “Polyethylene Glycol Electrolytes Powder (PEG-4000)” NCT04247386 ↗ |
| Route | Oral | “Powder for oral solution.” NCT00255372 ↗ |